An Update on Treatment of Drug-Induced Liver Injury.

Abstract

Drug-induced liver injury (DILI) has been linked to more than 1,000 medications and remains the most common cause of acute liver failure in the United States. Here, we review the most current literature regarding treatment and make recommendations for the management of this relatively common disease. Since treatment of DILI remains largely elusive, recent studies have attempted to define new management strategies for these difficult patients. Early diagnosis and withdrawal of the suspected medication is the mainstay of treatment of DILI. For acetaminophen and Amanita mushroom poisoning, there are specific therapies in use. Finally, there are other possible management modalities for DILI, including corticosteroids and ursodeoxycholic acid.

• Authors: Christin Giordano, John Rivas, Xaralambos Zervos
• Journal: Journal of clinical and translational hepatology (J Clin Transl Hepatol) Vol. 2 Issue 2 Pg. 74-9 (Jun 2014) ISSN: 2225-0719 [Print] United States
• PMID: 26356645 (Publication Type: Journal Article, Review)